According to a new report published by Allied Market Research, titled, “Animal Model Market by Animal Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030,"the global animal model market was valued at $1,469 million in 2020, and is projected to reach $2,677 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.
Animal models refer to those animals on which pathological and biological experiments are performed & tested. Animal models are utilized as animals and human beings share important physiological & organic structures. In addition, some of the animal species share nearly similar genetic structure to humans. Thus, animal models are utilized by scientists and researchers to study & find a cure for diseases, test the final medicinal drugs before it is used on humans, and also to develop new products. New drugs are examined in animals for safety & efficacy before they are examined in humans. Moreover, animal models find applications in drug discovery & development, basic research, and others.
Increase in demand for animal model to perform various studies on diseases and human physiology, increase in awareness among researchers about physiological similarities between humans & animals, rise in importance of genetics in biomedical studies, surge in preference of animal testing in R&D, and rise in usage of animal models in the pre-clinical development by several research laboratories and biopharmaceutical industries are the major factors that boost the growth of the market. In addition, increase in innovations in animal models, surge in demand for personalized medicine, increase in pipeline of pharmaceutical & biopharmaceutical companies, and increase in government support for the innovation & development of standard protocols allied with animal models are other factors that further drive the growth of the market. However, regulations and laws for ethical use of animals in research are expected to restrain the growth of the animal model market. Conversely, growth opportunities in emerging markets are expected to offer lucrative opportunities during the forecast period.
Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. There is rise in demand for COVID-19 mouse models, specifically for humanized ACE2 (hACE2) mice, which express humanized ACE2 in the airway & other epithelia and develops a lethal SARS-CoV infection. Moreover, governments and scientific research institutions in many countries are bound to increase research investments in vaccines and treatments against contagious diseases such as COVID-19. The increase in demand for therapeutics & vaccines against COVID-19 is anticipated to drive the animal model market during the forecast period.
The animal model market is segmented into animal type, application, end user, and region.
On the basis of animal type, the animal model market is categorized into rat, mice, guinea pigs, rabbits, and others. Presently, the rat segment dominated the global animal model market in 2020, and is anticipated to continue this trend during the forecast period. Key factors, such as increase in usage of rat models to study several complex disorders, rise in demand for rat model in biomedical research for understanding the existing health issues, and rise in advancements in gene editing tools, drive the growth of the market. In addition, surge in consumption of personalized medicine in developing & developed countries, continuous support by governments in the form of investments & grants, and technological advancements in gene editing tools further drive the growth of the market.
By application, the animal model market is divided into drug discovery & development, basic research, and others. The drug discovery & development segment is anticipated to depict significant growth during the forecast period due to increase in adoption of animal models in drug discovery & development, production of novel products by pharmaceuticals & biotechnology companies, and rise in preclinical activities and toxicity testing during drug development.
Key Findings of The Study:
- Based on animal type, the rat segment held the largest market share in 2020, and is expected to remain dominant during the forecast period.
- On the basis of application, the drug discovery & development segment held the largest market share in 2020, and is expected to remain dominant during the forecast period.
- On the basis of end user, the pharma & biotech companies segment held the largest market share in 2020, and is expected to remain dominant during the forecast period.
- Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.3% during the forecast period.
In 2020, North America accounted for the major share in the animal model market, owing to increase in preclinical activities by pharmaceutical and biotech companies during drug development, rise in use of animal models by CROs, and surge in focus on personalized medicines. However, Asia-Pacific is projected to register the fastest growth rate during the forecast period, owing to increase in research on biomedical and regenerative medicine, increase in awareness related to animal models, and availability of trained medical professionals.